F. Wightman

发表

HIV Reservoirs and Strategies for Eradication

S. Lewin, Miranda Z. Smith, M. Z. Smith, 2012, Current HIV/AIDS Reports.

Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa

Michael I. Jordan, Donald A. Jackson, J. G. Ndirangu, 2016, Journal of the International AIDS Society.

Cancer therapies in HIV cure research

S. Lewin, T. Rasmussen, Jenny L Anderson, 2017, Current opinion in HIV and AIDS.

ExVivo Response to Histone Deacetylase (HDAC) Inhibitors of the HIV Long Terminal Repeat (LTR) Derived from HIV-Infected Patients on Antiretroviral Therapy

M. Churchill, S. Lewin, S. Wesselingh, 2014 .

Both CD31(+) and CD31⁻ naive CD4(+) T cells are persistent HIV type 1-infected reservoirs in individuals receiving antiretroviral therapy.

S. Lewin, N. Saksena, P. Gorry, 2010, The Journal of infectious diseases.

Coinfection of Hepatic Cell Lines with Human Immunodeficiency Virus and Hepatitis B Virus Leads to an Increase in Intracellular Hepatitis B Surface Antigen

Suha M. Saleh, S. Lewin, P. Revill, 2010, Journal of Virology.

Altering cell death pathways as an approach to cure HIV infection

S. Lewin, A. Badley, A. Sainski, 2013, Cell Death and Disease.

Severe hepatitis and prolonged hepatitis B virus-specific CD8 T-cell response after selection of hepatitis B virus YMDD variant in an HIV/hepatitis B virus-co-infected patient

S. Lewin, J. Torresi, J. Sasadeusz, 2004, AIDS.

Comparison of Sequence Analysis and a Novel Discriminatory Real-Time PCR Assay for Detection and Quantification of Lamivudine-Resistant Hepatitis B Virus Strains

S. Lewin, S. Locarnini, S. Bowden, 2004, Journal of Clinical Microbiology.

The phenotype of hepatitis B virus–specific T cells differ in the liver and blood in chronic hepatitis B virus infection

S. Lewin, S. Kent, S. Locarnini, 2007, Hepatology.

Highly reproducible transient transfections for the study of hepatitis B virus replication based on an internal GFP reporter system.

S. Lewin, J. Torresi, Theo Gouskos, 2004, Journal of virological methods.

No Increase in Hepatitis B Virus (HBV)-Specific CD8+ T Cells in Patients with HIV-1-HBV Coinfections following HBV-Active Highly Active Antiretroviral Therapy

S. Lewin, K. Ruxrungtham, S. Sirivichayakul, 2010, Journal of Virology.

Enhanced Replicative Capacity and Pathogenicity of HIV-1 Isolated From Individuals Infected With Drug-Resistant Virus and Declining CD4+ T-Cell Counts

S. Lewin, P. Gorry, N. Lane, 2005, Journal of acquired immune deficiency syndromes.

Reduced Hepatitis B Virus (HBV)-Specific CD4+ T-Cell Responses in Human Immunodeficiency Virus Type 1-HBV-Coinfected Individuals Receiving HBV-Active Antiretroviral Therapy

S. Lewin, S. Kent, J. Sasadeusz, 2005, Journal of Virology.

Understanding Factors That Modulate the Establishment of HIV Latency in Resting CD4+ T-Cells In Vitro

S. Lewin, P. Cameron, K. Cheong, 2016, PloS one.

Expression and reactivation of HIV in a chemokine induced model of HIV latency in primary resting CD4+ T cells

Suha M. Saleh, S. Lewin, D. Purcell, 2011, Retrovirology.

Establishment of HIV-1 latency in resting CD4+ T cells depends on chemokine-induced changes in the actin cytoskeleton

G. Boucher, S. Lewin, R. Sékaly, 2010, Proceedings of the National Academy of Sciences.

Activation of HIV Transcription with Short-Course Vorinostat in HIV-Infected Patients on Suppressive Antiretroviral Therapy

D. Hazuda, S. Lewin, R. Sékaly, 2014, PLoS pathogens.

Ex Vivo Response to Histone Deacetylase (HDAC) Inhibitors of the HIV Long Terminal Repeat (LTR) Derived from HIV-Infected Patients on Antiretroviral Therapy

M. Churchill, S. Lewin, S. Wesselingh, 2014, PloS one.

Effect of ipilimumab on the HIV reservoir in an HIV-infected individual with metastatic melanoma.

S. Lewin, C. McNeil, S. Palmer, 2015, AIDS.

CCR7 ligands CCL19 and CCL21 increase permissiveness of resting memory CD4+ T cells to HIV-1 infection: a novel model of HIV-1 latency.

Suha M. Saleh, S. Lewin, P. Cameron, 2007, Blood.

HDAC inhibitors in HIV

M. Churchill, S. Lewin, P. Ellenberg, 2012, Immunology and cell biology.

Comparison of HDAC inhibitors in clinical development Effect on HIV production in latently infected cells and T-cell activation

S. Lewin, C. Dinarello, J. Melchjorsen, 2013 .

No adverse safety or virological changes 2 years following vorinostat in HIV-infected individuals on antiretroviral therapy

S. Lewin, D. Purcell, H. Prince, 2017, AIDS.

Comparison of HDAC inhibitors in clinical development

S. Lewin, C. Dinarello, J. Melchjorsen, 2013, Human vaccines & immunotherapeutics.

Entinostat is a histone deacetylase inhibitor selective for class 1 histone deacetylases and activates HIV production from latently infected primary T cells

Suha M. Saleh, M. Churchill, S. Lewin, 2013, AIDS.

The novel histone deacetylase inhibitors metacept-1 and metacept-3 potently increase HIV-1 transcription in latently infected cells

S. Lewin, A. Dear, H. B. Liu, 2009, AIDS.

A randomised controlled trial of oral zinc on the immune response to tuberculosis in HIV-infected patients.

S. Lewin, N. Paton, T. Ravindran, 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Virologic Determinants of Success After Structured Treatment Interruptions of Antiretrovirals in Acute HIV-1 Infection

S. Lewin, D. Cooper, A. Kelleher, 2008, Journal of acquired immune deficiency syndromes.

Establishment of HIV-1 latency in resting CD4+ T cells depends on chemokine-induced changes in the actin cytoskeleton

Suha M. Saleh, G. Boucher, S. Lewin, 2010, Proceedings of the National Academy of Sciences.

Virologic Determinants of Success After Structured Treatment Interruptions of Antiretrovirals in Acute HIV-1 Infection

S. Lewin, D. Cooper, A. Kelleher, 2008, Journal of acquired immune deficiency syndromes.

The novel histone deacetylase inhibitors metacept-1 and metacept-3 potently increase HIV-1 transcription in latently infected cells

Suha M. Saleh, A. Dear, F. Wightman, 2009, AIDS.